New Delhi: Pfizer, the world's largest pharmaceutical company, has said that the Omicron vaccine will be ready in March, which could be a glimmer of hope in the face of rising Omicron cases. “The Omicron vaccine will be available by March, but current vaccines have provided 'reasonable' protection against the Omicron strain of COVID-19” said the Pfizer Chief Executive Officer Albert Bourl.
"In March, this vaccination will be available... I'm not sure if we'll need it. I'm not sure if or how it'll be used " Bourla stated. Experts believe that a vaccine targeting Omicron could protect against future infections and mutations of the variant.
Moderna concentrated on Omicron-targeted boosters.In a separate stateemnt, Moderna CEO Stephane Bancel stated that the company is working on developing a booster dose that might treat Omicron and other mutations that may arise as a result of the variant.
"We're talking to public health leaders all over the world to figure out the best plan for a possible booster in the fall of 2022. We must be cautious in order to remain ahead of a virus rather than behind it "Bancel said.